Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Campylobacter is a genus of Gram-negative, motile, spiral-shaped bacteria, with Campylobacter jejuni being the most common cause of human bacterial gastroenteritis worldwide [1]. These bacteria are primarily microaerophilic and are frequently found in the gastrointestinal tracts of wild and domestic animals, particularly poultry, which serve as the main reservoir for human infection [2]. In humans, infection typically occurs via the fecal-oral route through the consumption of contaminated food or water, leading to campylobacteriosis characterized by inflammatory, often bloody, diarrhea, abdominal pain, and fever [3]. While the infection is often self-limiting, it can lead to severe systemic complications or post-infectious autoimmune disorders such as Guillain-Barré syndrome, which is triggered by molecular mimicry between bacterial lipooligosaccharides and human nerve gangliosides [4]. Treatment usually involves supportive care, but severe or prolonged cases are managed with antibiotics like macrolides or fluoroquinolones, although rising antimicrobial resistance is a significant global health concern [5].
Antibiotics targeting Campylobacter typically act by inhibiting bacterial protein synthesis through binding to the 50S (macrolides) or 30S (tetracyclines, aminoglycosides) ribosomal subunits, or by inhibiting DNA replication through the inhibition of DNA gyrase and topoisomerase IV (fluoroquinolones) [3, 5].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Campylobacter.